Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 29 Jan 2020 for ACHILLION PHARMACEUTICALS INC, €515k.
Filing timeline
BuySaleJason S. Fisherman
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Jason S. Fisherman: trading record in brief
Jason S. Fisherman is a declared insider of Achillion Pharmaceuticals Inc, with filings sourced from SEC (Form 4). In total, 6 filings cover trades dated from 22 December 2016 to 28 January 2020.
Purchases make up the whole of the open-market record (1 purchase, €38k). Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 2 option exercises.
The newest entry dates from 29 January 2020: a transaction of €515k, in Achillion Pharmaceuticals Inc. The last insider purchase was made public on 23 December 2016, 3,592 days ago. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Jason S. Fisherman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
90,000 shares@ US$6.3088.3% of flowCommon StockSEC:0001562180-20-000670:0
1,500 shares@ US$6.301.5% of flowCommon StockSEC:0001562180-20-000670:1
20,000 shares@ US$3.2810.2% of flowCommon StockSEC:0001562180-19-005524:0
20,000 shares@ US$1.052.8% of flowCommon StockSEC:0001209191-18-036667:0
1,500 shares0Common StockSEC:0001209191-17-042522:0
10,000 shares@ US$3.965.9% of flowCommon StockSEC:0001209191-16-156623:0
Canonical exit: 22 Mar 2017 (T+90)
6 of 6 declarations
